News

Metabolic Solutions Development Company (MSDC) has received a $100,000 grant from the Alzheimer’s Drug Discovery Foundation (ADDF) to support the evaluation of PPAR-sparing insulin sensitizers as a potential

The NIH has awarded 22 grants to Kaiser Permanente researchers in various regional centers, including a $25 million Grand Opportunities grant to conduct genotyping on 100,000 Kaiser Permanente

Fermentation of undigested foods in the colon by its resident bacteria affects not only colonic health (protection against inflammation and tumour formation) but also influences metabolic health. Studying

Sinclair Pharma has completed the acquisition of two dermatology products Flammazine and Flammacerium from Solvay Pharmaceuticals for a total consideration of £17.5 million – reported Pharmacy Choice. The

Pfizer has suspended patient enrollment in its late-stage lung cancer study of figitumumab, also known as CP-751871, due to serious adverse events, including deaths – reported Trading Markets.

Czura Thornton has signed an agreement to acquire the global central laboratory (GCL) operations of MDS Pharma Services, a business unit of MDS Pharma Services. Reportedly, GCL provides

BASF SE (Deutsche Börse: BAS) and The Dow Chemical Company, have jointly come forward to support the Patent Asset Index (PAI), a new methodology that measures research and

Orion Genomics has entered into a multi-year collaboration and license agreement with the molecular diagnostics unit of Novartis. As per the agreement, the parties seek to discover novel

PhysioNetics has received a $750,000 phase II grant from National Institutes of Health (NIH) to continue its development work on an new ‘gripper’ for upper-extremity prostheses. The fund